Synovial Sarcoma Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

SIX1 as a Novel Immunohistochemical Marker in the Differential Diagnosis of Rhabdomyosarcoma
Conclusion: SIX1 immunohistochemistry is positive in most RMS, and occasionally in some tumors within the differential diagnoses of RMS.PMID:37224459 | DOI:10.1080/15513815.2023.2214806 (Source: Fetal and Pediatric Pathology)
Source: Fetal and Pediatric Pathology - May 24, 2023 Category: Pathology Authors: Daniel Ehinger Hanna Frostberg Sofia Larsson David Gisselsson Source Type: research